Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2026 Filed May 28, 2026 20:25 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
Exercise / conversionPerformance Share Unit · Derivative | 17,093 | $0.00 | $0.00 |
DisclosureSEC source: 0001984186-26-000002 · wk-form4_1779999927.xml · derivative · entry 2 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 17,093 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: The performance share units vested on April 24, 2026. F4 · derivative.expiration_date: The performance share units vested on April 24, 2026. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:25 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
Exercise / conversionOrdinary Shares | 18,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001984186-26-000002 · wk-form4_1779999927.xml · nonDerivative · entry 1 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 · balance_after: Includes 781 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:25 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Exercise / conversionPerformance Share Unit · Derivative | 14,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001708062-26-000004 · wk-form4_1779999902.xml · derivative · entry 2 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,517 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: The performance share units vested on April 24, 2026. F4 · derivative.expiration_date: The performance share units vested on April 24, 2026. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:25 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Exercise / conversionOrdinary Shares | 15,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001708062-26-000004 · wk-form4_1779999902.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 · balance_after: Includes 270 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:24 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Exercise / conversionPerformance Share Unit · Derivative | 1,621 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-26-000008 · wk-form4_1779999857.xml · derivative · entry 2 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,621 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F3 · derivative.exercise_date: The performance share units vested on April 24, 2026. F3 · derivative.expiration_date: The performance share units vested on April 24, 2026. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:24 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Exercise / conversionOrdinary Shares | 1,712 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-26-000008 · wk-form4_1779999857.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026, of which 1,027 shares will be delivered to the reporting person when her employment with the Company ends. Read SEC document |
| May 01, 2026 Filed May 4, 2026 21:12 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Tax withholdingOrdinary Shares | 35 | $80.00 | $2,800.00 |
DisclosureSEC source: 0002028475-26-000002 · wk-form4_1777929145.xml · nonDerivative · entry 1 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,380 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 367 shares acquired through dividend reinvestment and 191 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 20:16 UTC |
Lofton Kevin EDirector
|
Tax withholdingOrdinary Shares | 207 | $81.90 | $16,953.30 |
DisclosureSEC source: 0001468818-26-000002 · wk-form4_1777493804.xml · nonDerivative · entry 2 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,140 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 20:13 UTC |
Fonseca LidiaDirector
|
Tax withholdingOrdinary Shares | 207 | $81.90 | $16,953.30 |
DisclosureSEC source: 0001454944-26-000002 · wk-form4_1777493591.xml · nonDerivative · entry 2 Fonseca Lidia · CIK 0001454944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,644 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 20:18 UTC |
Powell Kendall JDirector
|
Tax withholdingOrdinary Shares | 207 | $81.90 | $16,953.30 |
DisclosureSEC source: 0001298823-26-000002 · wk-form4_1777493878.xml · nonDerivative · entry 2 Powell Kendall J · CIK 0001298823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,380 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 20:12 UTC |
DONNELLY SCOTT CDirector
|
Tax withholdingOrdinary Shares | 207 | $81.90 | $16,953.30 |
DisclosureSEC source: 0001233158-26-000008 · wk-form4_1777493560.xml · nonDerivative · entry 2 DONNELLY SCOTT C · CIK 0001233158 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,679 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 20:12 UTC |
ARNOLD CRAIGDirector
|
Tax withholdingOrdinary Shares | 207 | $81.90 | $16,953.30 |
DisclosureSEC source: 0001188578-26-000003 · wk-form4_1777493521.xml · nonDerivative · entry 2 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,185 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 20:14 UTC |
HOGAN RANDALL JDirector
|
Tax withholdingOrdinary Shares | 207 | $81.90 | $16,953.30 |
DisclosureSEC source: 0001189049-26-000002 · wk-form4_1777493693.xml · nonDerivative · entry 2 HOGAN RANDALL J · CIK 0001189049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,998 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 20:18 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Tax withholdingOrdinary Shares | 318 | $81.90 | $26,044.20 |
DisclosureSEC source: 0002061393-26-000006 · wk-form4_1777493911.xml · nonDerivative · entry 2 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,262 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 20:17 UTC |
NABEL ELIZABETH GDirector
|
Tax withholdingOrdinary Shares | 207 | $81.90 | $16,953.30 |
DisclosureSEC source: 0001619929-26-000002 · wk-form4_1777493842.xml · nonDerivative · entry 2 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,584 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 20:16 UTC |
Lewis Gregory PDirector
|
Tax withholdingOrdinary Shares | 207 | $81.90 | $16,953.30 |
DisclosureSEC source: 0001748656-26-000002 · wk-form4_1777493774.xml · nonDerivative · entry 2 Lewis Gregory P · CIK 0001748656 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,754 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:15 UTC |
Lee Joon SupDirector
|
GrantOrdinary Shares | 1,803 | $0.00 | $0.00 |
DisclosureSEC source: 0002075730-26-000002 · wk-form4_1777493747.xml · nonDerivative · entry 1 Lee Joon Sup · CIK 0002075730 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,803 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:16 UTC |
Lofton Kevin EDirector
|
GrantOrdinary Shares | 2,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001468818-26-000002 · wk-form4_1777493804.xml · nonDerivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,347 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 65 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:13 UTC |
Fonseca LidiaDirector
|
GrantOrdinary Shares | 2,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001454944-26-000002 · wk-form4_1777493591.xml · nonDerivative · entry 1 Fonseca Lidia · CIK 0001454944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,851 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 65 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:18 UTC |
Powell Kendall JDirector
|
GrantOrdinary Shares | 2,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001298823-26-000002 · wk-form4_1777493878.xml · nonDerivative · entry 1 Powell Kendall J · CIK 0001298823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,587 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 854 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:12 UTC |
DONNELLY SCOTT CDirector
|
GrantOrdinary Shares | 2,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001233158-26-000008 · wk-form4_1777493560.xml · nonDerivative · entry 1 DONNELLY SCOTT C · CIK 0001233158 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,886 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 145 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:12 UTC |
ARNOLD CRAIGDirector
|
GrantOrdinary Shares | 2,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001188578-26-000003 · wk-form4_1777493521.xml · nonDerivative · entry 1 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,392 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 65 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:14 UTC |
HOGAN RANDALL JDirector
|
GrantOrdinary Shares | 2,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001189049-26-000002 · wk-form4_1777493693.xml · nonDerivative · entry 1 HOGAN RANDALL J · CIK 0001189049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,205 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 65 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:15 UTC |
Jellison William RDirector
|
GrantOrdinary Shares | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001189883-26-000002 · wk-form4_1777493719.xml · nonDerivative · entry 1 Jellison William R · CIK 0001189883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,444 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:13 UTC |
Groetelaars John PDirector
|
GrantOrdinary Shares | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001580664-26-000002 · wk-form4_1777493618.xml · nonDerivative · entry 1 Groetelaars John P · CIK 0001580664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,444 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:18 UTC |
Blomquist Denise L.Chief Accounting Officer
|
GrantOrdinary Shares | 1,508 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-26-000006 · wk-form4_1777493911.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,580 F1 · shares: Represents restricted stock units that vest in three annual installments beginning one year from the date of grant. F2 · balance_after: Includes 106 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:17 UTC |
NABEL ELIZABETH GDirector
|
GrantOrdinary Shares | 2,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001619929-26-000002 · wk-form4_1777493842.xml · nonDerivative · entry 1 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,791 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 65 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:16 UTC |
Lewis Gregory PDirector
|
GrantOrdinary Shares | 2,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001748656-26-000002 · wk-form4_1777493774.xml · nonDerivative · entry 1 Lewis Gregory P · CIK 0001748656 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,961 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 65 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 22:22 UTC |
Pieton ThierryEVP & Chief Financial Officer
|
Tax withholdingOrdinary Shares | 2,976 | $96.71 | $287,808.96 |
DisclosureSEC source: 0001613103-26-000003 · wk-form4_1772749333.xml · nonDerivative · entry 1 Pieton Thierry · CIK 0002056622 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,574 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 592 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:19 UTC |
Blomquist Denise L.Chief Accounting Officer
|
GiftOrdinary Shares | 340 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-26-000004 · wk-form4_1771967954.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,966 Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 385 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · derivative · entry 11 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,155 Underlying: Ordinary Shares · 385 shares Expires 2034-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 19,923 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · derivative · entry 10 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,926 Underlying: Ordinary Shares · 19,923 shares Expires 2033-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,568 | $0.00 Strike: $93.08 | $0.00 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · derivative · entry 9 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,606 Underlying: Ordinary Shares · 30,568 shares Expires 2032-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
SaleOrdinary Shares | 385 | $97.82 | $37,660.70 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 8 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,768 Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
SaleOrdinary Shares | 668 | $97.83 | $65,347.10 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 7 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,153 Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
SaleOrdinary Shares | 19,255 | $97.77 | $1,882,561.35 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 6 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,821 Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
SaleOrdinary Shares | 30,568 | $97.66 | $2,985,374.81 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 5 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,076 F2 · price: The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $97.60 to $97.775. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
SaleOrdinary Shares | 1,648 | $97.86 | $161,273.28 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 4 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,644 Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Exercise / conversionOrdinary Shares | 385 | $80.00 | $30,800.00 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 3 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Exercise / conversionOrdinary Shares | 19,923 | $87.76 | $1,748,442.48 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 2 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Exercise / conversionOrdinary Shares | 30,568 | $93.08 | $2,845,269.44 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 239 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:06 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Tax withholdingOrdinary Shares | 148 | $101.00 | $14,948.00 |
DisclosureSEC source: 0002061393-26-000002 · wk-form4_1770066410.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,306 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 97 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:18 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Tax withholdingOrdinary Shares | 439 | $99.87 | $43,842.93 |
DisclosureSEC source: 0001473812-25-000004 · wk-form4_1766006325.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,749 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to reporting person's retirement eligibility. F2 · balance_after: Includes 251 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:17 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Tax withholdingOrdinary Shares | 1,564 | $99.87 | $156,196.68 |
DisclosureSEC source: 0001560409-25-000005 · wk-form4_1766006222.xml · nonDerivative · entry 1 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,393 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to reporting person's retirement eligibility. F2 · balance_after: Includes 832 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:18 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
Tax withholdingOrdinary Shares | 1,371 | $99.87 | $136,921.77 |
DisclosureSEC source: 0001984186-25-000003 · wk-form4_1766006302.xml · nonDerivative · entry 1 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,818 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to reporting person's retirement eligibility. F2 · balance_after: Includes 250 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 21:11 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
Tax withholdingOrdinary Shares | 1,702 | $101.36 | $172,514.72 |
DisclosureSEC source: 0001708062-25-000005 · wk-form4_1765314675.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,177 F1 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 264 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 21:17 UTC |
Blomquist Denise L.Chief Accounting Officer
|
GiftOrdinary Shares | 170 | $0.00 | $0.00 |
DisclosureSEC source: 0002061393-25-000004 · wk-form4_1764019068.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,357 F1 · balance_after: Includes 99 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 21:13 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
SaleOrdinary Shares | 500 | $102.08 | $51,040.00 |
DisclosureSEC source: 0001533098-25-000005 · wk-form4_1763759581.xml · nonDerivative · entry 7 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,016 Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 21:13 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
SaleOrdinary Shares | 325 | $102.06 | $33,169.50 |
DisclosureSEC source: 0001533098-25-000005 · wk-form4_1763759581.xml · nonDerivative · entry 6 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,516 Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 21:13 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
SaleOrdinary Shares | 227 | $102.05 | $23,165.35 |
DisclosureSEC source: 0001533098-25-000005 · wk-form4_1763759581.xml · nonDerivative · entry 5 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,841 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.